Letter to the EditorContinued Response to One Dose of Nivolumab Complicated by Myasthenic Crisis and Myositis
Under an Elsevier user license
open archive
Cited by (0)
Disclosure: The authors declare no conflict of interest.
© 2017 International Association for the Study of Lung Cancer. Published by Elsevier Inc.